Table 2.
Utilization Adjusted OR (95% CI)* | |||||
---|---|---|---|---|---|
Variable | Primary Care Visit | Specialty Care Visit | Hospitalization | Home Health/Hospice Visit | No Outpatient or Inpatient Visit |
CD4 cell count | |||||
≥200/mm3 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
100–199/mm3 | 1.45 (0.94 to 2.26) | 2.10 (1.33 to 3.32)† | 1.73 (0.95 to 3.12) | 2.32 (1.12 to 4.81)‡ | 0.51 (0.32 to 0.83)† |
50–99/mm3 | 1.35 (0.88 to 2.06) | 2.09 (1.33 to 3.29)§ | 2.84 (1.54 to 5.24)§ | 2.54 (1.11 to 5.78)‡ | 0.66 (0.4 to 1.09) |
0–49/mm3 | 2.21 (1.49 to 3.27)§ | 2.86 (1.91 to 4.27)§ | 2.95 (1.67 to 5.19)§ | 4.14 (2.06 to 8.34)§ | 0.31 (0.19 to 0.5)§ |
Severity of AIDS-defining illness | |||||
Low | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Medium | 0.92 (0.65 to 1.29) | 1.30 (0.92 to 1.86) | 1.35 (0.94 to 1.94) | 1.38 (0.82 to 2.33) | 0.93 (0.62 to 1.38) |
High | 0.91 (0.62 to 1.33) | 1.43 (0.94 to 2.18) | 1.10 (0.70 to 1.71) | 2.52 (1.41 to 4.51)† | 0.87 (0.53 to 1.42) |
Months since AIDS diagnosis | 0.99 (0.98 to 1.01) | 1.03 (1.01 to 1.04)§ | 1.00 (0.99 to 1.02) | 1.04 (1.02 to 1.05)§ | 1.00 (0.98 to 1.01) |
Period of care | |||||
Diagnosis period | 2.21 (1.74 to 2.80)§ | 1.42 (1.11 to 1.83)† | 2.67 (1.86 to 3.83)§ | 1.16 (0.84 to 1.59) | 0.35 (0.26 to 0.46)§ |
Interim period | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
End-of-life period | 0.60 (0.47 to 0.77)§ | 0.90 (0.68 to 1.18) | 6.51 (4.56 to 9.28)§ | 3.12 (2.33 to 4.18)§ | 0.63 (0.47 to 0.85)† |
Physician experience level | |||||
Least | 0.50 (0.32 to 0.77)† | 1.00‖ | 0.53 (0.32 to 0.88)‡ | 0.67 (0.33 to 1.38) | 2.46 (1.44 to 4.21)§ |
Moderate | 0.54 (0.39 to 0.74)§ | 1.79 (1.09 to 2.93)‡ | 0.69 (0.48 to 0.99)‡ | 0.93 (0.57 to 1.53) | 1.81 (1.22 to 2.68)† |
Most | 1.00 | 1.66 (1.04 to 2.65)‡ | 1.00 | 1.00 | 1.00 |
Odds ratios (ORs) were adjusted for all the other variables in the table.
Denotes P < .01.
Denotes P < .05
Denotes P < .001.
Reference category depicts the observed difference between moderate and most versus least experienced physicians.
CI, confidence interval.